sofidexFor patientsAre you a clinician? Clinical site

Health Library  ›  News  ›  Health notices · Thursday 3 September

Updates ·

Health notices · Thursday 3 September

3 notices from the agencies today, in plain words, each with the original linked.

About 2 minutes to readNoticePublished September 2026

PDF
a plain paper envelope and an unopened cardboard box on a table

Recall expanded for frozen triple berry blend over possible E. coli contamination

Centers for Disease Control and Prevention (CDC) · Food safety

If you have the recalled Great Value frozen Organic Triple Berry Blend, the CDC says Frutas y Hortalizas del Sur S.A. has expanded its recall for one additional lot.

The concern is potential contamination with Escherichia coli (E. coli) O145, a type of bacteria that can cause stomach illness.

Check whether your package matches the recalled lot information from the July 3, 2026 recall expansion, published September 2, 2026.

Read the original notice

CDC can distribute diphtheria antitoxin for suspected cases

CDC · Guidance

If you are suspected of having respiratory diphtheria, CDC says diphtheria antitoxin (DAT) can be requested through an Food and Drug Administration (FDA) “expanded access” pathway because DAT is no longer produced in the United States.

DAT is for people who meet case definitions for suspect or confirmed respiratory diphtheria, or respiratory diphtheria-like illness from lab-confirmed toxigenic Corynebacterium ulcerans. A clinician decides whether DAT is needed after diagnosis review.

What to do

  • If your doctor suspects you need DAT, they should first consult your state health department and then call CDC.
  • If DAT is released for you but not used, it should be returned by the releasing process, shipped cold by overnight mail. (Your treating clinician will handle this.)

Read the original notice

World Health Organization (WHO) declares a public health emergency for Bundibugyo Ebola

WHO · Outbreak

If you are in the Democratic Republic of the Congo or Uganda, WHO says a high-mortality outbreak of Ebola disease caused by Bundibugyo virus has been identified, including deaths among health workers.

A species of Ebola virus disease, Bundibugyo virus disease was laboratory-confirmed in health-zone samples in Ituri Province (Mongbwalu and Rwampara areas) and an imported case in Kampala, Uganda.

WHO says there is no licensed vaccine or specific therapeutics for this virus; early supportive care can be lifesaving. WHO is supporting response, case management, and cross-border preparedness.

WHO response includes rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, safe treatment centers, and community engagement.

Read the original notice